US OptionsDetailed Quotes
LLY241206P725000
- 0.01
- -0.19-95.00%
15min DelayClose Dec 3 16:00 ET
1.01High0.01Low
0.73Open0.20Pre Close10 Volume404 Open Interest725.00Strike Price742.00Turnover52.78%IV10.86%PremiumDec 6, 2024Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.0054Delta0.0004Gamma12512.77Leverage Ratio-0.0592Theta-0.0003Rho-67.77Eff Leverage0.0109Vega
Eli Lilly and Co Stock Discussion
Sign in to post a comment
1
4
🚒🧯🚒🧯🚒🧯🚒🔥🔥🔥🔥🔥🔥🔥🚨🚨🚨🚨🚨
Don’t Miss The Wave 🌊 🏄♂️
STOCKS WITH AMAZING ROI %
$Vistra Energy (VST.US)$ is overlooked but outperformed most stocks in 2024
$NVIDIA (NVDA.US)$ as well as
SEZL DAVE LBPH ROOT SMR APP SUMMIT LUNR MSTR
.
Historic 2 Weeks Nov 25-29 December 2-7
• TOP TIER
BTC to $100K *
ETH to $4,000 *
NOW to $1041
LLY to $788.19
BRK.B to $483 *
MSFT to $423
PANW to $384.37
CRWD to $347.59
TSLA to $333 *
APP to $328.5...
Don’t Miss The Wave 🌊 🏄♂️
STOCKS WITH AMAZING ROI %
$Vistra Energy (VST.US)$ is overlooked but outperformed most stocks in 2024
$NVIDIA (NVDA.US)$ as well as
SEZL DAVE LBPH ROOT SMR APP SUMMIT LUNR MSTR
.
Historic 2 Weeks Nov 25-29 December 2-7
• TOP TIER
BTC to $100K *
ETH to $4,000 *
NOW to $1041
LLY to $788.19
BRK.B to $483 *
MSFT to $423
PANW to $384.37
CRWD to $347.59
TSLA to $333 *
APP to $328.5...
+55
77
20
5
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
well said Bro 
Today, $Amgen (AMGN.US)$ announced the P2 trial results for MariTide, which only include the safety profile for the 420 mg dose escalation cohorts (cherry-picking at it's finest again).
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
+1
3
$Eli Lilly and Co (LLY.US)$ Bio season gonna kick off early
1
$Eli Lilly and Co (LLY.US)$
If you can't tell yet that something smells fishy for the timing of the WSJ news about Biden passing law for Medicare accepting fatloss drug on holiday week. Then you deserve what is going to happen next.
It’s unusual for a major policy like expanding Medicare and Medicaid to cover weight-loss drugs to be proposed 30 days before a presidential term ends. Such changes require legislative approval or regulatory adjustments, both of w...
If you can't tell yet that something smells fishy for the timing of the WSJ news about Biden passing law for Medicare accepting fatloss drug on holiday week. Then you deserve what is going to happen next.
It’s unusual for a major policy like expanding Medicare and Medicaid to cover weight-loss drugs to be proposed 30 days before a presidential term ends. Such changes require legislative approval or regulatory adjustments, both of w...
7
10
No comment yet
Foodie Investor : Dude why u so negative abt lly
MonkeyGee OP Foodie Investor : sorry if it sounds negative, but I call it as I see it. The bright side is that I could be totally wrong.
70825143 : eli lilly and co is to the pharmaceutical industry as nvidia is to the semiconductors industry, no need to worry at all, if it falls again, just buy blindly.![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
Junius Falcon 70825143 : Dude was shorting NVDA back in October, now we don't see him there